Baxter International Inc. News Headlines

BAX 
$74.48
*  
0.41
0.55%
Get BAX Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading BAX now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Cerus Soaring On FDA Approval Of Intercept
12/19/2014 8:47:00 PM - Seeking Alpha


It's New! It's Nifty! It's The Dividend Growth 50!
12/17/2014 9:19:00 PM - Seeking Alpha


Baxter to Vend Vero Cell Vaccine Platform to Nanotherapeutics - Analyst Blog
12/16/2014 6:10:00 PM - Zacks.com


Zacks Rank #5 Additions for Tuesday - Tale of the Tape
12/16/2014 9:30:00 AM - Zacks.com


Baxter to Vend Vero Cell Vaccine Platform to Nanotherapeutics - Analyst Blog
12/16/2014 6:10:00 AM - Investopedia


Backtesting The New Nifty Fifty Using Weighted, Equal-Weight, And Random-Assignment Designs
12/15/2014 3:15:00 PM - Seeking Alpha


Baxter To Sell Proprietary Vero Cell Technology To Nanotherapeutics
12/15/2014 9:09:00 AM - RTT News


Baxter Files Form 10 with SEC, Advances Baxalta Spin-off - Analyst Blog
12/11/2014 12:40:00 PM - Zacks.com


Kamada Reports Interim Data From Human Alpha-1 Antitrypsin Clinical Study
12/11/2014 7:22:00 AM - RTT News


Nektar/AstraZeneca's Moventig Gets EU Approval for OIC - Analyst Blog
12/10/2014 6:50:00 PM - Zacks.com


BAX Makes Notable Cross Below Critical Moving Average
12/10/2014 4:02:46 PM - BNK Invest


The New Nifty Fifty: A Comparative Performance Analysis
12/8/2014 7:28:00 AM - Seeking Alpha


Baxter: Strong Sell on Prevailing Headwinds, Estimate Revision - Analyst Blog
12/5/2014 1:50:00 PM - Zacks.com


Zacks Rank #5 Additions for Friday - Tale of the Tape
12/5/2014 9:30:00 AM - Zacks.com


Will MedTech Gain from Republican Promises? - Industry Outlook
12/4/2014 1:00:00 PM - Investopedia


Mylan, Gilead Ink Deal for TAF-based HIV Drugs - Analyst Blog
12/2/2014 5:45:00 PM - Zacks.com


Momenta's Necuparanib Gets Fast Track Status in the U.S. - Analyst Blog
12/2/2014 3:10:00 PM - Zacks.com


Here's How Much Pfizer Will Increase Its Dividend This Month
12/2/2014 2:09:00 PM - Seeking Alpha


Baxter Files BLA for BAX 855 in Hemophilia A Treatment - Analyst Blog
12/2/2014 12:40:00 PM - Zacks.com


Baxter International Inc. (BAX) Ex-Dividend Date Scheduled for December 03, 2014
12/2/2014 9:00:01 AM - NASDAQ.com News


FDA Lifts Hold On FLXN Study, All''s Well With CPXX Trial, COMET Woes For EXEL
12/2/2014 12:58:00 AM - RTT News


Baxter Submits BLA For BAX 855
12/1/2014 9:27:00 AM - RTT News


Pfizer Closes Acquisition Of Baxter's Marketed Vaccines - Quick Facts
12/1/2014 7:33:00 AM - RTT News


Retirement Portfolio For Dummies - The Health Care Components
11/30/2014 1:42:00 PM - Seeking Alpha


ModernGraham Quarterly Valuation Of Baxter International
11/29/2014 6:07:00 AM - Seeking Alpha